Agile Therapeutics Insider Trades

-0.01 (-0.89 %)
(As of 07/27/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume1.25 million shs
Average Volume1.29 million shs
Market Capitalization$97.97 million
P/E RatioN/A
Dividend YieldN/A

Agile Therapeutics (NASDAQ:AGRX) Insider Buying and Selling Activity

5.60% of Agile Therapeutics' shares are owned by company executives, directors and other insiders. Over the past twelve months, Agile Therapeutics insiders have purchased shares 7 time(s), totalling $232,422.84. Insiders that have bought shares include Alfred Altomari, Dennis Reilly, and Jason Butch.

Insider Buying and Selling by Quarter

Agile Therapeutics (NASDAQ AGRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/18/2021Alfred AltomariCEOBuy20,000$1.61$32,200.00488,710  
5/11/2021Dennis ReillyCFOBuy20,000$1.35$27,000.00176,306  
3/29/2021Jason ButchInsiderBuy1,358$1.99$2,702.4218,642  
3/26/2021Jason ButchInsiderBuy8,642$2.01$17,370.4218,642  
3/23/2021Alfred AltomariCEOBuy12,500$2.00$25,000.00468,710  
3/23/2021Dennis ReillyCFOBuy50,000$2.05$102,500.00156,306  
9/28/2020Dennis ReillyCFOBuy9,000$2.85$25,650.00106,306  
3/13/2020Perceptive Advisors LlcMajor ShareholderBuy1,000,000$1.75$1,750,000.00  
3/4/2020Dennis ReillyCFOBuy50,000$2.32$116,000.0059,806  
2/27/2020Alfred AltomariCEOBuy10,000$2.71$27,100.00301,611  
2/25/2020Life Sciences Maste PerceptiveMajor ShareholderBuy3,000,000$3.02$9,060,000.00  
11/14/2019Perceptive Advisors LlcMajor ShareholderBuy435,015$1.69$735,175.35  
10/28/2019Perceptive Advisors LlcMajor ShareholderSell3,815,349$0.51$1,945,827.99  
8/6/2019Perceptive Advisors LlcMajor ShareholderBuy2,300,000$0.95$2,185,000.00  
6/10/2019Alfred AltomariCEOBuy20,000$1.27$25,400.00258,568  
3/29/2019Abhijeet J LeleDirectorBuy20,000$1.54$30,800.0037,949  
3/25/2019Alfred AltomariCEOBuy25,000$1.54$38,500.00238,568  
7/26/2018Life Sciences Maste PerceptiveInsiderSell298,628$0.30$89,588.40  
8/25/2017Alfred AltomariChairmanBuy10,000$3.34$33,400.00161,587  
8/25/2017Renee SelmanInsiderBuy7,250$3.35$24,287.5060,583  
5/11/2017Alfred AltomariChairmanBuy10,000$3.51$35,100.00151,587  
5/11/2017Renee SelmanInsiderBuy53,333$3.68$196,265.4453,333  
1/27/2016Jay MoorinMajor ShareholderBuy393,700$6.35$2,499,995.00  
6/2/2015Alfred AltomariCEOBuy2,500$8.73$21,825.00  
1/23/2015Jay MoorinMajor ShareholderBuy811,966$5.85$4,750,001.10  
5/29/2014Care Capital Iii LlcMajor ShareholderBuy500,000$6.00$3,000,000.00  
5/23/2014Andrew N SchiffDirectorBuy1,333,333$6.00$7,999,998.00  
5/22/2014Ab InvestorMajor ShareholderBuy1,000,000$6.00$6,000,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 7/28/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.